Zusammenfassung
Die Erforschung der erworbenen Immunität gegen Virusinfektionen verfolgt nicht nur das praktisch wichtige Ziel, eine Grundlage zu schaffen für die Anwendung von Schutzimpfungsverfahren und therapeutisch wirksamer Immunsera, sondern sie sucht bekanntlich auch, aus den beobachteten Immunitätsphänomenen Rückschlüsse zu ziehen auf die Natur der Virusarten als Infektionsstoffe.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literaturverzeichnis
1. Alexander: Studies on the neurotropic virus of Horsesickness. (1) I. Neuro-tropic fixation. Onderstepoort J. Vet. Sci. 4, 291 (1935).
Alexander: (2) II. Some physical and chemical properties. Onderstepoort J. Vet. Sci. 4, 323 (1935).
Alexander: (3) III. The intracerebral protection test and its application to the study of immunity. Onderstepoort J. Vet. Sci. 4, 349 (1935).
Alexander: (4) IV. The pathogenesis in horses. Onderstepoort J. Vet. Sci. 4, 379 (1935).
Alexander: (5) V. The antigenic response of horses to simultaneous trivalent immunization. Onderstepoort J. Vet. Sci. 7, 11 (1936).
Alexander: (6) The horsesickness problem in South Africa. J. Soc. amer. vet. Assoc. 7, (1936).
2. Amies: The particulate nature of avian sarcoma agents. J. Path. a. Bacter. 44, 141 (1937).
3. Andersen: (1) Über die Bedeutung des virusneutralisierenden Antikörpers für die Immunität. Z. Immunit. forsch. 90, 207 (1937).
Andersen: (2) Über angeborene Vaccineimmunität. Z. Immunit. forsch. 90, 459 (1937).
4. Andervont: The Pathogenicity on two strains of herpetic virus for mice. J. infect. Dis. (Am.) 45, 366 (1929).
5. Andrewes: (1) A study of virus III with special reference to the response of immunised rabbits to reinoculation. J. Path. a. Bacter. 31, 461 (1928).
Andrewes: (2) The action of immune serum on vaccinia and Virus III in vitro. J. Path. a. Bacter. 31, 671 (1928).
Andrewes: (3) Virus III in Tissue cultures. III. Experiments bearing on immunity. Brit. J. exper. Path. 10, 273 (1929).
Andrewes: (4) Antivaccinial serum. Protection against generalization in the rabbit. J. Path. a. Bacter. 32, 265 (1929).
Andrewes: (5) Antivaccinial serum. Evidence of slow union with virus in vitro. J. Path. a. Bacter. 33, 265 (1930).
Andrewes: (6) Tissue culture in the study of immunity to herpes. J. Path. a. Bacter. 33, 301 (1930).
Andrewes: (7) Immunity to the salivary gland virus of guinea pigs in the living animal and in tissue cultures. Brit. J. exper. Path. 11, 23 (1930).
Andrewes: (8) Some properties of immune sera active against fowl tumour viruses. J. Path. a. Bacter. 35, 243 (1932).
Andrewes: (9) Influence of the bacterial cell on the phage-antiphage reaction. Brit. J. exper. Path. 13, 851 (1932).
Andrewes: (10) Influenza: Four years progress. Brit. med. J. 2, 513 (1937).
6. Andrewes and Carmichael: A note on the presence of antibodies to herpes virus. Lancet 1930, 851.
7. Andrewes and Elford: Observations on anti-phage sera. I. “The percentage law.” Brit. J. exper. Path. 14, 366 (1933).
8. Andrewes, Laidlaw, and Smith: Influenza: observations on the recovery of virus from man and on the antibody content of human sera. Brit. J. exper. Path. 16, 566 (1935).
9. Andrewes and Smith: (1) Influenza: Further experiments on the active immunization of mice. Brit. J. exper. Path. 18, 43 (1937).
Andrewes and Smith: (2) The effect of foreign tissue extracts on the efficacy of influenza virus vaccines. Brit. J. exper. Path. 20, 305 (1939).
10. Armstrong and Lillie: Encephalitisvirus (St. Louis). Effect of partial specific immunity upon the clinical and pathologic picture in intracerebrally inoculated white mice. Publ. Health Rep. (Am.) 51, 1069 (1936).
11. Arnold and Weiss: A study of bacteriophage with antibacteriophagic serum. J. infect. Dis. (Am.) 35, 505 (1924).
12. Aycock and Hudson: The development of neutralizing substance for poliomyelitis virus in vaccinated and unvaccinated individuals. New Engl. J. Med. 214, 715 (1936).
13. Aycock and Kramer: Immunity to poliomyelitis in mothers and the new born as shown by the neutralization test. J. exper. Med. (Am.) 52, 457 (1930).
14. Baird and Rivers: Relation of lymphocytic choriomeningitis to acute aseptic meningitis (Wallgren). Amer. J. publ. Health 28, 47 (1938).
15. Balozet: Effet de réinoculations, chez l’âne, du virus de l’anémic infectieuse. C. r. Soc. Biol. 119, 160 (1935).
16. Beard, Finkelstein, Sealy, and Wyckoff: (1) The ultracentrifugal concentration of the immunizing principle from tissues diseased with equine encephalomyelitis. Science 87, 89 (1938).
Beard, Finkelstein, Sealy, and Wyckoff: (2) Immunization against equine encephalomyelitis with chick embryo vaccines. Science 87, 490 (1938).
17. Béclère, Chambon et Ménard: (1) Études sur l’immemité vaccinale et le pouvoir immemisant du serum de genisse vacciné. Ann. Inst. Pasteur, Par. 10, 1 (1896).
Béclère, Chambon et Ménard: (2) Étude sur l’immunité vaccinale. Ann. Inst. Pasteur, Par. 13, 81 (1899).
18. Béclère, Chambon, Ménard et Coulomb: Transmission intrautérine de l’immunité vaccinale et du pouvoir antivirulent du sérum. C. r. Acad. Sci. 129, 235 (1899).
19. Bedson: (1) Observations on the mode of action of a viricidal serum. Brit. J. exper. Path. 9, 235 (1928).
Bedson: (2) Immunization with killed Herpesvirus. Brit. J. exper. Path. 12, 254 (1931).
Bedson: (3) Immunological studies with the virus of psittacosis. Brit. J. exper. Path. 14, 162 (1933).
Bedson: (4) Some reflections on virus immunity. Proc. Soc. Med., Lond. 31, 59 (1937).
Bedson: (5) A study of experimental immunity to the virus of psittacosis in the mouse, with special reference to persistence of infection. Brit. J. exper. Path. 19, 353 (1938).
20. Bedson and Crawford: Immunity in experimental herpes. Brit. J. exper. Path. 8, 138 (1927).
21. Bedson, Maitland, and Burbury: Further observations on foot-and-mouth disease. J. comp. Path. a. Ther. 40, 79 (1927); Sec. Progr. Rep. Foot-and-Mouth Dis. Res. Com., p. 97. London, 1927.
22. Bernkopf and Kligler: Immunization of rabbits with inactive vaccine virus. J. Immunol. (Am.) 32, 451 (1937).
23. Bessho: Untersuchungen über die Schutzai]-und Heilkraft des Vaccineserums. Inauguraldiss., Bern, 1925.
24. Bieling: Untersuchungen über ein neurotropes Virus. Zbl. Bakter. usw., I Orig. 140, 154 (1937) (Beiheft).
25. Bieling u. Oelrichs: (1) Untersuchungen über die Verteilung des Grippevirus im Körper der Maus. Behringwerke Mitt., H. 9, 20 (1938).
Bieling u. Oelrichs: (2) Züchtung von Vaccinevirus auf den Eiern vorbehandelter Hühner. Behringwerke Mitt., H. 9, 64 (1938).
26. Bigleri: Immunité des éctodermoses neurotropes. C. r. Soc. Biol. 94, 447 (1926).
27. Bland: Immunization with inactive vaccinia virus. J. Hyg. (Brit.) 32, 55 (1932).
28. Boecker: Tierversuche zur Frage der immunisatorischen Wirksamkeit von Wutschutzimpfstoffen aus formalinisiertem Virus fixe. Z. Hyg. usw. 121, 735 (1939).
29. Brachmann: Zur Frage der Virulenzbestimmung durch Verdünnung des virushaltigen Materiales bei Maulai]-emd Klauenseuche. Dtsch. tierärztl. Wschr. 1925, 554.
30. Bridé et Bardach: Essais de sérothérapie préventive antivaccinale. Ann. Inst. Pasteur, Par. 60, 270 (1938).
31. Bridé et Boquet: La vaccination anticlaveleuse par virus sensibilisé. Après dix ans d’application. Ann. Inst. Pasteur, Par. 37, 229 (1923).
32. Brodie: (1) Active immunization against poliomyelitis. J. exper. Med. (Am.) 56, 493 (1932).
Brodie: (2) Active immunization in monkeys against poliomyelitis with germicidally inactivated virus. J. Immunol. (Am.) 28, 1 (1935).
Brodie: (3) The rôle of convalescent serum in preparalytic poliomyelitis. J. Immunol. (Am.) 28, 353 (1935).
33. Brodie, Fischer, and Stillerman: NeutraIization tests in poliomyelitis. Sera taken during the acute and convalescent stages of the disease and tested with a passage virus and astrain isolated during the 1935 New York City outbreak. J. clin. Invest. (Am.) 16, 447 (1937).
34. Brodie and Goldbloom: Active immunization against poliomyelitis in monkeys. J. exper. Med. (Am.) 53, 885 (1931).
35. Burnet: (1) Immunological studies with phage-coated bacteria. Brit. J. exper. Path. 14, 93 (1933).
Burnet: (2) Immunological studies with the virus of infectious laryngotracheitis of fowls using the developing egg technique. J. exper. Med. (Am.) 63, 685 (1936).
Burnet: (3) Inapparent (sub-clinical) infection of the rat with louping-ill virus. J. Path. a. Bacter. 42, 213 (1936).
Burnet: (4) Influenza virus on the developing egg. I. Changes associated with development of an egg-passage strain of virus. Brit. J. exper. Path. 17, 282 (1936).
Burnet: (5) II. The “neutralization” of egg virus by immune sera. Austral. J. exper. Biol. a. med. Sci. 14, 247 (1936).
Burnet: (6) IV. The pathogenicity and immunizing power of egg virus for ferrets and mice. Brit. J. exper. Path. 18, 37 (1937).
Burnet: (7) V. Differentiation of two antigenic types of human influenza virus. Austral. J. exper. Biol. a. med. Sci. 15, 369 (1937).
36. Burnet and Galloway: The propagation of the virus of vesicularstomatitis in the chorion allantoic membrane of the developing hen’s egg. Brit. J. exper. Path. 15, 105 (1934).
37. Burnet, Kellaway, and Williams: Cellular immunity and antibody in the tissue spaces. J. Path. a. Bacter. 35, 199 (1932).
38. Burnet, Keogh, and Lush: The immunological reactions of the filterable viruses. Austral. J. exper. Biol. a. med. Sci. 15, 233 (1937).
39. Burnet and Lush: (1) Inapparent (sub-clinical) infection of the rat with the virus of infectious ectromelia of mice. J. Path. a. Bacter. 42, 469 (1936).
Burnet and Lush: (2) Influenza on the developing egg. VII. The antibodies of experimental and human sera. Brit. J. exper. Path. 19, 17 (1938).
40. Burnet and Macnamara: Immunological differences between strains of poliomyelitis virus. Brit. J. exper. Path. 12, 57 (1931).
41. Busson: Das Übertreten und die Speicherung von Virus fixe im Zentralnervensystem geimpfter Menschen und Tiere. Zbl. Bakter. usw., I Orig. 135, 331 (1935/36).
42. Busson u. Schweinburg: cit. nach Schweinburg (310).
43. Camus: Immunité vacçinale active et immunité vaccinale passive. C. r. Soc. Biol. 73, 197, 294 (1912).
44. Casagrandi: L’immunità passiva nel vaccino e nel vaiolo. Ann. Ig. sper. 25, 17 (1925).
45. Clifton, Mueller, and Rogers: Neutralization of the bacteriophage. J. Immunol. (Am.) 29, 377 (1935).
46. Cole and Kuttner: A filterable virus present in the submaxillary glands of guinea pigs. J. exper. Med. (Am.) 44, 855 (1926).
47. Collier: Übertragung des Geflügelpestvirus auf Mäusegehirn und Rattenhoden. Z. Hyg. usw. 113, 751 (1932).
48. Cook: The response of specifically immunised mice to reinoculation with the virus of St. Louis encephalitis, with especial attention to the development of myelitic symptoms. J. infect. Dis. (Am.) 63, 206 (1938).
49. Covell, McGuire, Stephens, and Lahiri: Notes on antirabic immunization. Indian J. med. Res. 24, 373 (1936).
50. Cox: Tissue cultures as a more sensitive method than animal inoculation for detecting equine encephalomyelitis virus. Proc. Soc. exper. Biol. a. Med. (Am.) 33, 607 (1936).
51. Cox and Olitzky: (1) Prevention of experimental equine encephalomyelitis in guinea pigs by means of virus adsorbed on aluminium hydroxid. Science 79, 459 (1934).
Cox and Olitzky: (2) Active immunization of guinea pigs with the virus of equine encephalomyelitis. II. Immunization with formolized virus. J. exper. Med. (Am.) 63, 745 (1936).
Cox and Olitzky: (3) Quantitative studies of serum-antiviral bodies in animals immunized with active and inactive virus. J. exper. Med. (Am.) 64, 217 (1936).
Cox and Olitzky: (4) Active immunization of guinea pigs with the virus of equine encephalomyelitis. Effect of immune serum on antigenicity of active and inactive virus. J. exper. Med. (Am.) 64, 223 (1936).
52. Craigie: A comparison of the antigenic qualities of killed and living vaccine virus in the normal rabbit. J. Bacter. (Am.) 27, 77 (1934).
53. Craigie and Tulloch: Further investigations on the variola-vaccine flocculation reaction. Med. Res. Counc. London Spec. Rep. Ser. Nr. 156 (1931).
54. Croveri: Sulla receltività alle vaccinazione dei vitelli anti da mare immune verso la peste bovina. Bull. Soc. Path. exot. 12, 2 (1919).
55. Cruveilhier, Lépine et Viala: Pouvoir rabicide du sérum sanguin de lapins vaccinés contre la rage comparativement par la méthode des moelles déssechées et au moyens du vaccin phéniqué. Ann. Inst. Pasteur, Par. 61, 487 (1938).
56. Cunningham, Malone, and Craighead: An investigation into the value of an etherized vaccine in the prophylacted treatment of rabies. Indian med. Res. Mem. Nr. 26, 1 (1933).
57. da Fano and Perdrau: Chronic or subacute herpetic meningo-encephalitis in the rabbit with calcification. J. Path. a. Bacter. 30, 67 (1927).
58. Davis: On the use of immune serum at various intervalls after the inoculation of yellow fever virus into rhesus monkeys. J. Immunol. (Am.) 26, 361 (1934).
59. Degkwitz: Über Masernrekonvalescentenserum. Z. Kinderhk. 25, 134 (1920); 27, 171 (1920).
60. Doerr: Die Schienenimmunisierung. Klin. Wschr. Nr. 30, 1062 (1936).
61. Doerr u. Berger: Herpes, Zoster und Encephalitis. Weichhardtsche Erg. 8, 1415 (1930).
62. Doerr u. Hallauer: Die primäre Herpesmyelitis und ihre Beziehungen zum Infektionsmodus sowie zur Wirtsspezies. Z. Hyg. usw. 118, 474 (1936).
63. Doerr u. Kon: Schieneninfektion, Schienenimmunisierung und Konkurrenz der Infektionen im Z. N. S. beim Herpesvirus. Z. Hyg. usw. 119, 679 (1937).
64. Doerr u. Seidenberg: (1) Ungewöhnlich hohe Grade des anaphylaktischen Zustandes. Z. Immunit. forsch. 69, 169 (1930/31).
Doerr u. Seidenberg: (2) Zur kongenitalen Anaphylaxie des Meerschweinchens. Z. Immunit. forsch. 71; 242 (1931).
Doerr u. Seidenberg: (3) Untersuchungen über das Virus der Hühnerpest. VIII. Mitteilung. Z. Hyg. usw. 114, 276 (1932).
Doerr u. Seidenberg: (4) Die Konkurrenz von Virusinfektionen im Zentralnervensystem (Phänomen von Fl. Magrassi). Z. Hyg. usw. 119, 135 (1937).
65. Doerr, Seidenberg u. Whitman: Untersuchungen über das Virus der Hühnerpest. a) Z. Hyg. usw. 112, 732 (1931). b) Z. Hyg. usw. 113, 671 (1939).
66. Douglas and Smith: A study of vaccinial immunity in rabbits by means of in vitro methods. Brit. J. exper. Path. 11, 96 (1930).
67. Douglas, Smith, and Price: Generalized vaccinia in rabbits with especial reference to lesions in the internal organs. J. Path. a. Bacter. 32, 99 (1929).
68. Downie and McGaughey: Experiments with the virus of infectious ectromelia. The action of immUne serum in vivo and on the growth of virus in culture. J. Path. a. Bacter. 40, 297 (1935).
69. Dresel: Beziehungen zwischen Lapineinnnunität und Nachweis von Lapine-virus beim Kaninchen. Z. Immunit. forsch. 75, 337 (1932).
70. Eichhorn and Wyckoff: Immunological studies on equine encephalomyelitis. J. amer. vet. med. Assoc. 93 (46), 285 (1938).
71. Enders and Shaffer: Behaviour exhibited by mixtures of pneUIllococcus type III and homologous antiserUIll analogous to that described for similar association of virus and antiviral serum. J. Immunol. (Am.) 32, 379 (1937).
72. Ernst: Weitere Mitteilungen über die Frage des Infektionsablaufes und der Immunität bei Maulai]-und Klauenseuche. Münch. tierärztl. Wschr. 74, 181 (1923).
73. Fairbrother: (1) Immunization of the horse with the virus of poliomyelitis and the production of an antiviral serum. Brit. J. exper. Path. 11, 43 (1930).
Fairbrother: (2) The action of antivaccinial serum on the vaccinia virus. J. Path. a. Bacter. 35, 35 (1932).
Fairbrother: (3) The production of immunity to vaccinia virus by mixtures of immune serum and virus and the importance of phagocytosis in antivaccinial immunity. J. Path. a. Bacter. 36, 55 (1933).
74. Fairbrother and Hoyle: Active immunization against experimental influenza: The use of heat-killed elementary body suspensions. Brit. J. exper. Path. 18, 430 (1937).
75. Fermi: Comparaison entre le pouvoir lyssicide et immunisant du sérum antirabique de différents animaux et de différents instituts. Zbl. Bakter. usw., I Orig. 52, 576 (1909).
76. Findlay: (1) The fractionation of anti vaccinia serum. Brit. J. exper. Path. 12, 9 (1931).
Findlay: (2) The transmission of louping-ill to monkeys. Brit. J. exper. Path. 13, 230 (1932).
Findlay: (3) The mechanism of immunity in Rift Valley fever. Brit. J. exper. Path. 17, 89 (1936).
77. Findlay and Olarke: Reconversion of the neurotropic into the viscerotropic strain of yellow fever virus in rhesus monkeys. Trans. Soc. trop. Med. 28, 579 (1935).
78. Findlay and Hindle: Combined use of living virus and immune serum for immunization against virus infections. Brit. med. J. 1, 740 (1931).
79. Findlay and McCallum: An interference phenomenon in relation to yellow fever and other viruses. J. Path. a. Bacter. 44, 405 (1937).
80. Findlay and Mackenzie: Attempts to produce immunity against yellow fever with killed virus. J. Path. a. Bacter. 43, 205 (1936).
81. Findlay, Mackenzie, and Stern: Studies on neurotropic Rift Valley fever virus: The susceptibility of sheep and monkeys. Brit. J. exper. Path. 17, 431 (1936).
82. Findlay and Stern: The essential neurotropism of the yellow fever virus. J. Path. a. Bacter. 41, 431 (1935).
83. Fischer, A.: Untersuchungen über die natürliche Immunität gegen Roussarkom. Z. Krebsforsch. 24, 580 (1927).
84. Flexner: (1) Contributions to the pathology of experimental virus encephalitis. IV. Recurring strains of herpes virus. J. exper. Med. (Am.) 47, 9 (1928).
Flexner: (2) Immunity to human and passage poliomyelitisvirus. J. amer. med. Assoc. 99, 1244 (1932).
85. Flexner and Amoss: (1) The relation of the meninges and choroid plexus to poliomyelitic infection. J. exper. Med. (Am.) 25, 525 (1917).
Flexner and Amoss: (2) Experiments on the nasal route of infection in poliomyelitis. J. exper. Med. (Am.) 31, 123 (1920).
Flexner and Amoss: (3) Varieties and properties of the herpes virus. J. exper. Med. (Am.) 41, 357 (1925).
86. Flexner and Lewis: Experimental poliomyelitis in monkeys. VII. Active immunization and passive serum protection. J. amer. med. Assoc. 54, 1780 (1910); 55, 662 (1910).
87. Flexner and Stewart: Protective action of convalescent poliomyelitis serum. J. amer. med. Assoc. 91, 383 (1928).
88. Fortner: Sur la question de l’immunité contre la psittacose. Bull. Off. internat. Hyg. publ., Par. 28, 683 (1936).
89. Fortner u. Pfaffenberg: Über das gehäufte Wiederauftreten der Psittacosis. Z. Hyg. usw. 116, 397 (1935).
90. Francis: (1) Epidemiology studies in influenza. Amer. J. publ. Health 27, 211 (1937).
Francis: (2) Quantitative relationships between the immunizing dose of epidemic influenza virus and the resultant immunity. J. exper. Med. (Am.) 69, 283 (1939).
91. Francis and Magill: (1) Rift Valley fever. A Report of three cases of laboratory infection and the experimental transmission of the disease to ferrets. J. exper. Med. (Am.) 62, 433 (1935).
Francis and Magill: (2) Immunological studies with the virus of influenza. J. exper. Med. (Am.) 62, 505 (1935).
Francis and Magill: (3) The incidence of neutralizing antibodies for human influenza virus in the serum of human individuals of different ages. J. exper. Med. (Am.) 63, 655 (1936).
Francis and Magill: (4) The antibody response of human subjects vaccinated with the virus of human influenza. J. exper. Med. (Am.) 65, 251 (1937).
92. Francis, Magill, Rickard, and Beck: Etiological and serological studies in epidemic influenza. Amer. J. publ. Health 27, 1141 (1937).
93. Francis and Shope: Neutralization tests with sera of convalescent or immunized animals and the viruses of swine and human influenza. J. exper. Med. (Am.) 63, 645 (1936).
94. Francis and Stuart-Harris: Studies on the nasal histology of epidemic influenza virus infection in the ferret. III. Histological and serological observations on ferrets receiving repeated inoculations of epidemic influenza virus. J. exper. Med. (Am.) 68, 813 (1938).
95. Freund: (1) Passive Immunisierung mit Herpes-Antiserum. Zbl. Bakter. usw., I Orig. 119, 20 (1930).
Freund: (2) Accumulation of antibodies in the central nervous system. J. exper. Med. (Am.) 51, 889 (1930).
96. Galli: L’immunità verso la superinfezione nell’infezione vaccinica, studiata in vitro. Boll. Ist. sieroter. milan. 16, 482 (1937).
97. Galli e Verotti: L’immunità locale verso il virus vaccinico: Contributo allo studio deI meccanismo della immunità edella infezione latente. Ann. Ig. 49, (1939) (im Druck).
98. Galli et Vieuchange: (1) La réactivation par la dialyse du neurovaccin formolé. C. r. Soc. Biol. 131, 473 (1939).
Galli et Vieuchange: (2) Action de la trypsine sur le neurovaccin formolé. C. r. Soc. Biol. 131, 715 (1939).
99. Galloway: The “fixed” virus of rabies: The antigenie value of the virus inactivated by the photodynamic action of methylen blue and proflavine. Brit. J. exper. Path. 15, 97 (1934).
100. Gastinel: Des réactions d’infection et d’immunité dans la vaccine et la variole. Thèse de Paris, Steinheil, 1913.
101. Gastinel et Reilly: Apropos des herpès récidivants. Bull. méd. 42, 839 (1928).
102. Gastinel, Reilly et Mortier: Les réactions humorales chez le lapin soumis à des injections de vacein jennerien tué. C. r. Soc. Biol. 108, 474 (1931).
103. Gastinel, Stefanesco et Reilly: Sur la culture du virus herpétique in vitro et les modifications subies par ce virus. C. r. Soc. Biol. 106, 450 (1931).
104. Gerlach: Menschen als Psittacosisträger nach “stummer” Infektion mit Psittacosisvirus. Z. Hyg. usw. 118, 709 (1936).
105. Gildemeister u. Ahlfeld: (1) Experimentelle Studien mit Herpesvirus an der weibßn Maus. Zbl. Bakter. usw., I Orig. 139, 325 (1937).
Gildemeister u. Ahlfeld: (2) Über eine bei der weißen Maus spontan aufgetretene Meningoencephalomyelitis. Zbl. Bakter. usw., I Orig. 142, 144 (1938).
106. Gildemeister u. Herzberg: Experimentelle Untersuchungen über Herpes. Klin. Wschr. Nr. 13, 603 (1927).
107. Glanzmann: Akute Exantheme. Masern. Handbuch der inneren Medizin, herausgegeben von Bergmann u. Stachelin, 3. Aufl., Bd. 1, S. 303 (1934).
108. Gordon, M. H.: Studies of the viruses of vaccinia and variola. Med. Res. Counc. Spec. Rep. Ser. No. 98 (1925).
109. Gordon, F. B.: Active and passive iInmunity in experimental acute anterior Poliomyelitis. Thesis, University of Chicago, 1936. Arch. Path. (Am.) 21, 558 (1936).
110. Gordon, W. S.: Louping-ill. Proc. Soc. Med., Lond. 27, II (1934); Vet. Rec. 14, 1 (1934).
111. Gordon, Hudson, and Harrison: Active and passive immunization in experimental poliomyelitis. J. infect. Dis. (Am.) 64, 241 (1939).
112. Gordon and Hughes: A study of inactivated yellow fever virus as an immunizing agent. J. Immuno1. (Am.) 30, 221 (1936).
113. Goyal: Experiments on reactivation of the virus in neutral serum-virus mixtures. J. Immunol. (Am.) 29, 111 (1935).
114. Green, Ziegler, Green, Shillinger, Dewey, and Carlson: Epizootic Fox Encephalitis. VII. Nature of the immunity. Amer. J. Hyg. 21, 366 (1935).
115. Greig, Brownlee, Wilson, and Gordon: The nature of Louping-ill. Vet. Rec. 11, 325 (1931).
116. Grigorieff: Sur le mode d’inactivation des bactériophages. C. r. Soc. Biol. 96, 1141 (1927).
117. Gye and Purdy: (1) The cause of cancer. London: Cassel & Co., 1931.
Gye and Purdy: (2) The infective agent in tumour filtrates: A further investigation by means of antisera to normal tissues. Brit. J. exper. Path. 14, 250 (1933).
118. Haagen: (1) Weitere Untersuchungen über das Verhalten des Gelbfiebervirus in der Gewebekultur. Zbl. Bakter. usw., I Orig. 128, 13 (1933).
Haagen: (2) Über die Notwendigkeit lebender Zellen zur Viruszüchtung. Weitere Untersuchungen über das Gelbfieber-, Variola-Vakzineai]-und Herpesvirus. Zbl. Bakter. usw., I Orig. 129, 237 (1933).
Haagen: (3) Yellow fever virus in tissue culture. Arch. exper. Zellforsch. 15, 405 (1934).
119. Haendel, Gildemeister u. Schmitt: Über Auswertung von Vaccine und Vaccine-immunseris. Zbl. Bakter. usw., I Orig. 85, 126 (Beiheft) (1920).
120. Hall: Investigations on rinderpest immunization. Thesis, Zürich.
121. Hallauer: (1) Immunitätsstudien bei Hühnerpest I. Z. Hyg. usw. 116, 456 (1934).
Hallauer: (2) Immunitätsstudien bei Hühnerpest II. Über das Schicksal von Hühnerpestvirus im immunisierten Tierkörper. Z. Hyg. usw. 117, 451 (l935).
Hallauer: (3) Immunitätsstudien bei Hühnerpest III. Über aktive Immunisierung mit formalinisiertem Virus. Z. Hyg. usw. 117, 711 (1936).
Hallauer: (4) Immunitätsstudien bei Hühnerpest. IV. Mitteilung. Z. Hyg. usw. 118, 605 (1936).
Hallauer: (5) Über die Immunisierung des Zentralnervensystems mit einem nichtencephalitogenen Herpesstamm. Z. Hyg. usw. 119, 213 (1937).
Hallauer: (6) Über die passive Immunisierung des Zentralnervensystems gegenüber Herpesai]-und Hühnerpestvirus. Z. Hyg. usw. 119, 505 (1937).
Hallauer: (7) Studien über die Variabilität des Hühnerpestvirus im Gewebsexplantat. Arch. f. Virusforsch. 1, 70 (1939).
122. Hammerschmidt: Die Wirkungsweise anti infektiöser Sera. Zbl. Bakter. usw., I Orig. 142, 168 (1938).
123. Harde: Some observations on the virus of vaccinia. Ann. Inst. Pasteur, Par. 30, 299 (1916).
124. Harmon and Harkins: The significance of neutralizing substances in resistance and recovery from poliomyelitis. J. amer. med. Assoc. 107, 552 (1936).
125. Hartley: On the immune bodies occuring in anti-Rinderpest-serum and on the variations occuring in the serum proteins during Rinderpest and during immunization and hyperimmunization. Mem. Dept. Agric. India Vet. Sci. No. 4, 178 (1914).
126. Hedler: Beitrag zur Frage der Vererbung der Immunität bei Maulai]-und Klauenseuche. Inauguraidiss., München, 1932.
127. Henseval: Apropos de l’action spécifique de l’euglobuline du sérum vaccinal. C. r. Soc. Biol. 82, 1071, 1074 (1919).
128. Henseval et Convent: Recherche sur l’immunité vaccinale. Étude des propriétés du sérum des animaux vaccinés. Bull. Acad. Méd. Belg., Brux. 26, 251 (1912).
129. Herzberg: Der Vorgang der Vaccinevirusvermehrung in der Zelle. Zbl. Bakter. usw., I Orig. 136, 257 (1936).
130. Hindle: (1) A yellow fever vaccine. Brit. med. J. 1, 976 (1928).
Hindle: (2) The duration of yellow fever immunity. Lancet 1930, 451.
Hindle: (3) The transmission of yellow fever. Lancet 1930, 835.
Hindle: (4) An attempt to demonstrate residual virus in monkeys which had recovered from yellow fever. Brit. J. exper. Path. 13, 135 (1932)
131. Hlava u. Honl: Serum vaccinicum und seine Wirkungen. Wien. klin. Rdsch. 1895, 625, 643.
132. Hodes, Lavin, and Webster: Antirabic immunization with culture virus rendered avirulent by ultra-violet light. Science 86, 447 (1937).
133. Hodes and Webster: Relation between degree of immunity of mice following vaccination with St. Louis Encephalitis virus and the titre of the protective antibodies of the serum. J. exper. Med. (Am.) 68, 263 (1938).
134. Hoff u. Silberstein: Experimentelle Encephalitisstudien. II. Mitteilung. Über Immunisierungsversuche mit Encephalitisvirus. Z. exper. Med. 44, 257 (1925).
135. Horsfall: Neutralization of epidemic influenza virus. The linear relationship between the quantity of serum and the quantity of virus neutralized. J. exper. Med. (Am.) 70, 209 (1939).
136. Hoskins: (1) Protection properties against yellow fever virus in the sera of the offspring of immune rhesus monkeys. J. Immunol. (Am.) 26, 391 (1934).
Hoskins: (2) A protective action of neurotropic against viscerotropic yellow fever virus in macacus rhesus. Amer. J. trop. Med. 15, 675 (1935).
137. Howitt: (1) Poliomyelitis. I. Production of antiviral serum by inoculation of goats and sheep with the virus of poliomyelitis. J. infect. Dis. (Am.) 50, 26 (1932).
Hoskins: (2) Comparison of intramuscular injection with combined intraspinial and intravenous injection of convalescent serum in the treatment of experimental poliomyelitis in monkeys. J. infect. Dis. (Am.) 50, 47 (1932).
Hoskins: (3) Equine Encephalomyelitis. J. infect. Dis. (Am.) 51, 493 (1932).
Hoskins: (4) Further studies on the immunization of sheep to the virus of poliomyelitis with a comparison of neutralization tests using the old and arecent strain of virus. J. infect. Dis. (Am.) 53, 145 (1933).
Hoskins: (5) Immunization of guinea pigs to the virus of equine encephalomyelitis. J. infect. Dis. (Am.) 54, 368 (1934).
Hoskins: (6) An immunological study in laboratory animals of thirteen different strains of equine encephalomyelitis virus. J. Immunol. (Am.) 29, 319 (1935).
Hoskins: (7) A recently isolated strain of poliomyelitis virus. Science 85, 268 (1937).
Hoskins: (8) Method of transmission of immunity to equine encephalomyelitic virus in the guinea pig. J. iniect. Dis. (Am.) 61, 88 (1937).
Hoskins: (9) The moscow 2 strain of equine encephalomyelitic virus as compared with other strains oi equine encephalitis viruses. J. infect. Dis. (Am.) 63, 269 (1938).
138. Hoyt and Guerley: (1) Experimental street virus rabies in white mice. Studies on passive immunization. Proc. Soc. exper. Biol. a. Med. (Am.) 37, 454 (1937).
Hoyt and Guerley: (2) Proc. Soc. exper. Biol. a. Med. (Am.) 38, 40 (1938).
139. Hoyt, Fisk, and Moore: Experimental rabies in white mice. Studies on passive immunization. Proc. Soc. exper. Biol. a. Med. (Am.) 32, 1560 (1935).
140. Hoyt, Fisk, Moore, and Tracy: Experimental rabies in white mice. II. Studies on passive immunization. J. infect. Dis. (Am.) 69, 152 (1936).
141. Hudson, Bauer, and Philip: Protection tests with serum of persons recovered from yellow fever in the Western Hemisphere and West Africa. Amer. J. trop. Med. 9, 1 (1929).
142. Hudson and Beaudette: Infection of the c10aca with the virus of infectious bronchitis. Science 76, 34 (1932).
143. Hudson, Lennette, and Gordon: Factors of resistence in experimental poliomyelitis. J. amer. med. Assoc. 106, 2037 (1936).
144. Hudson and Philip: Infectivity of blood during the course of experimental yellow fever. J. exper. Med. (Am.) 50, 583 (1929).
145. Hudson, Philip, and Davis: Protection tests with serum of persons recovered from yellow fever in the Western Hemisphere and West Africa. Additional report. Amer. J. trop. Med. 9, 223 (1929).
146. Hunt and Falk: Some experiments on the antigenie properties of vaccine virus. J. Immunol. (Am.) 14, 347 (1927).
147. Hurst: Infection of the rhesus monkey and the guinea pig with the virus of equine encephalomyelitis. J. Path. a. Bacter. 42, 271 (1936).
148. Jamuni and Holden: The rôle of leucocytes in immunity to herpes. J. Immunol. (Am.) 26, 395 (1934).
149. Jonesco-Mihaiesti, Tupa et Mesrobeanu: Sur le virus poliomyélitique de Roumanie en 1928. C. r. Soc. Biol. 100, 919 (1929).
150. Jonesco-Mihaiesti, Tupa et Wisner: Sur un virus de poliomyélite s’atténuant au cours des passages. C. r. Soc. Biol. 99, 12 (1928).
151. Jonnesco: Le sort du virus rabique fixe dans le cerveau des chiens immunisés. C. r. Soc. Biol. 113, 1249 (1933).
152. Jouan et Staub: Étude sur la peste aviaire. Ann. Inst. Pasteur, Par. 34, 343 (1920).
153. Jungeblut: On the mechanism of immunity in experimental poliomyelitis. J. infect. Dis. (Am.) 58, 150 (1936).
154. Jungeblut and Hazen: Failure to immunize the monkey against poliomyelitis by prolonged nasopharyngeal spraying with live virus. Proc. Soc. exper. Biol. a. Med. (Am.) 28, 1004 (1931).
155. Jwanoff: Aktive Immunisierung mit Form01vaccine gegen Vaccine. Berl. tierärztl. Wschr. 1927, 752.
156. Kasahara: Über die Immunitätsverhä1tnisse des mit Ultraschallwellen behandelten Virus bei experimenteller Affenpoliomyelitis. Klin. Wschr. Nr. 28, 971 (1939).
157. Kasahara u. Ogata: Über die Vaccineimmunität der mit Ultraschallwellen vorbehandelten Pockenlymphe. Klin. Wschr. Nr. 21, 753 (1939).
158. Kawamura, Kodama, Ito, Yasaki, and Kobayakawa: Epidemic encephalitis in Japan. Arch. Path. (Am.) 22, 510 (1936); Kitasato Arch. exper. Med. (e.) 13, 281 (1936).
159. Keogh: (1) Titration of vaccinia virus on the chorioallantoic membrane of the chick-embryo and its application to immunological studies of neuro-vaccinia. J. Path. a. Bacter. 43, 441 (1936).
Keogh: (2) The kinetics of formalin disinfection of vaccinia virus. Austral. J. exper. Biol. a. med. Sci. 15, 109 (1937).
160. Kidd: Immunological reactions with a virus causing papillomas in rabbits. III. Antigenicity and pathogenicity of extracts of the growth of wild and domestic species: general discussion. J. exper. Med. (Am.) 68, 737 (1938).
161. Kidd, Beard, and Rous: Serological reactions with a virus causing rabbit papillomas which become cancerous. II. Test on the blood of animals carrying various epithelial tumours. J. exper. Med. (Am.) 64, 79 (1936).
162. Kimura u. Fujisawa: (1) Pockenstudien in der Gewebezüchtung. II. Bildung des viruliziden Stoffes in vitro. Z. Immunit. forsch. 71, 550 (1931).
Kimura u. Fujisawa: (2) III. Verhalten des Pockenvirus in immunem Gewebe bzw. Plasma. Z. Immunit. forsch. 74, 384 (1932).
163. Kitchevatz: Effet préventif du sérum antiherpétique dans l’herpès experimental. C. r. Soc. Biol. 116, 682 (1934).
164. Kolmer: (1) Antibody in relation to immunity in acute poliomyelitis. J. Immunol. (Am.) 31, 119 (1936).
Kolmer: (2) Active immunization against acute anterior poliomyelitis with ricinoleated vaccine. J. Immunol. (Am.) 32, 341 (1937).
165. Kolle u. Hetsch: Weitere Untersuchungen über Pest, im besonderen über Pestimmunität. Z. Hyg. 48, 368 (1904).
166. Konradi: Die Vererbung der Immunität gegen Lyssa. Zbl. Bakter. usw., I Orig. 52, 497 (1909).
167. Koppisch: Die Erzeugung einer primären Myelitis des Lendenmarkes durch intravenöse Injektion von Herpesvirus. Z. Hyg. usw. 117, 635 (1935).
168. Köves: La maladie d’Aujeszky. Bull. Mens. Off. internat. Epizoot. 59, 1 (1935).
169. Köves u. Hirt: Über die Aujeszkysche Krankheit der Schweine. Arch. wiss. u. prakt. Tierheilk. 68, 1 (1934).
170. Kramer: (1) Active Immunization against poliomyelitis. A comparative study. I. Attempts at immunization of monkeys and children with formalized virus. J. Immunol. (Am.) 31, 167 (1936).
Kramer: (2) III. Active immunization of monkeys with exactly neutralized mixtures of virus and serum. J. Immunol. (Am.) 31, 191 (1936).
171. Kramer and Grossman: Active immunization against poliomyelitis. A comparative study. II. Experimental immunization of monkeys with virus treated with sodium ricinoleat. J. Immunol. (Am.) 31, 183 (1936).
172. Kramer, Grossman, and Hoskwith: Active immunization against poliomyelitis. A comparative study. IV. Experimental immunization of monkeys with purified virus, adsorbed on Al(OH)3. J. Immunol. (Am.) 31, 199 (1936).
173. Kramer, Schaefer, and Park: Poliomyelitis. Active immunization-method for producing detectable amounts of neutralizing substances in macaccus rhesus with non infective mixtures of immun-serum and virus. J. Immunol. (Am.) 27, 199 (1935).
174. Kraus u. Doerr: Über das Verhalten des Hühnerpestvirus im Zentralnervensystem empfänglicher, natürlich und künstlich unempfänglicher Tiere. Zbl. Bakter. usw., I Orig. 46, 709 (1908).
175. Kraus u. Fukuhara: cit. nach Schweinburg (310). Neuere Ergebnisse der Tollwutforschung. Weichhardtsche Erg. 20, 1 (1938).
176. Kraus u. Holobut: Über die Wirkung des intraoculär injicierten rabiciden Serums. Z. Immunit. forsch. 3, 130 (1909).
177. Kraus, Keller u. Clairmont: Über das Verhalten des Lyssavirus im Zentralnervensystem empfänglicher, natürlich immuner und immunisierter Tiere. Z. Hyg. 41, 486 (1902).
178. Krontowski u. Hach: Versuche zum Studium der Immunität beim Fleckfieber unter Anwendung der Gewebekulturmethode. Arch. exper. Zellforsch. 3, 297 (1927).
179. Lagrange: (1) Apropos des neuro-infections auto-stérilisables. C. r. Soc. Biol. 100, 544 (1929).
Lagrange: (2) Apropos des neuro-infections autostérilisables. Les autostérilisations locales. C. r. Soc. Biol. 102, 278 (1929).
Lagrange: (3) Sur l’épidémiologie expérimentale de la pseudopeste aviaire d’Égypte. C. r. Soc. Biol. 103, 979 (1930).
Lagrange: (4) Réactions du cerveau au cours de l’immunité contre la peste aviaire. C. r. Soc. Biol. 104, 1161 (1930).
Lagrange: (5) Sur l’autostérilisation mortelle des poules vaccinées contre la peste aviaire d’Égypte. C. r. Soc. Biol. 106, 1080 (1931).
Lagrange: (6) L’autostérilisation mortelle de la peste aviaire d’Égypte est un phénomène épidémique. C. r. Soc. Biol. 106, 1081 (1931).
180. Laidlaw and Dunkin: (1) Studies in dog distemper. J. comp. Path. a. Ther. 44, 1 (1931).
Laidlaw and Dunkin: (2) Studies in dog distemper. IV. The immunization of ferrets against dog distemper. J. comp. Path. a. Ther. 41, 209 (1928).
181. Laidlaw, Smith, Andrewes, and Dunkin: Influenza: The preparation of immune sera in horses. Brit. J. exper. Path. 16, 275 (1935).
182. Ledingham and McClean: The propagation of vaccine virus in the rabbit dermis. Brit. J. exper. Path. 9, 216 (1928).
183. Ledingham, Morgan, and Petrie: The potency and distribution in the serum fractions of antiviral body obtained by i=unization of the horse with vaccinia virus. Brit. J. exper. Path. 12, 357 (1931).
184. le Fèvre de Arric: L’Herpès chronique du lapin. C. r. Soc. Biol. 90, 651 (1924).
185. Leiner u. Wiesner: Experimentelle Untersuchungen über Poliomyelitis acuta anterior. Wien. klin. Wschr. 1910, 323.
186. Lennette and Hudson: On the relationship between humoral and tissue immunity in experimental poliomyelitis. J. infect. Dis. (Am.) 65, 78 (1939).
187. Lépine: (1) Action de la cataphorèse sur le virus encephalitique. Recupération du virus par la cataphorèse. C. r. Soc. Biol. 104, 760 (1930).
Lépine: (2) Essais sur l’immunisation expérimentale des simiens contre la poliomyélite. Rev. Immunol. (Fr.) 1, 480 (1935).
188. Lépine et Sautter: (1) Essais expérimentaux sur la valeur pratique des vaccins antirabiques phéniqués. Ann. Inst. Pasteur, Par. 59, 39 (1937).
Lépine et Sautter: (2) État du virus fixe dans les vaccins antirabiques phéniqués. C. r. Soc. Biol. 127, 192 (1938).
Lépine et Sautter: (3) cit. nach Lépine. Ultravirus et immunité. IV. Congresso Int. di Path. Comp. I, 19 (1939).
189. Lépine, Cruveilhier et Sautter: Recherches sur la virulence des moelles rabiques en relation avec l’état actuel du virus fixe de l’institut Pasteur. Ann. Inst. Pasteur, Par. 55, 127 (1935).
190. Lesne et Dreyfus-Sée: Immunité locale cutanée antivariolique chez l’enfant de moins de 3 mois. C. r. Soc. Biol. 98, 919 (1928).
191. Levaditi, Kling et Haber: Est-il possible de vacciner l’homme contre la poliomyélite? Bull. Acad. Méd., Par. 115, 431 (1936).
192. Levaditi et Lépine: Recherches par la cataphorèse du virus poliomyélitique dans la moelle de singes atteints de lésions chroniques. C. r. Soc. Biol. 106, 34 (1931).
193. Levaditi, Lépine et Schoen: Modification de la virulence des virus encéphalitogènes. C. r. Soc. Biol. 101, 116 (1929).
194. Levaditi et Mutermilch: (1) Action de la toxine diphtérique sur la survie des cellules in vitro. C. r. Soc. Biol. 74, 379 (1913).
Levaditi et Mutermilch: (2) Action de la ricine sur la vie et la multiplication des cellules in vitro. C. r. Soc. Biol. 74, 611 (1913).
Levaditi et Mutermilch: (3) La sérothérapie antidiphtérique préventive et curative des éléments cellulaires, à l’état de vie prolongée in vitro. C. r. Soc. Biol. 74, 614 (1913).
Levaditi et Mutermilch: (4) Sérothérapie antivenimeuse sur les cellules en état de vie prolongée et de multiplication in vitro. C. r. Soc. Biol. 74, 1379 (1913).
195. Levaditi et Nicolau: (1) L’immunité dans les éctodermoses neurotropes: Herpès et encéphalite. C. r. Soc. Biol. 86, 228 (1922).
Levaditi et Nicolau: (2) Immunité du névraxe dans la vaccine. C. r. Soc. Biol. 86, 233 (1922).
Levaditi et Nicolau: (3) Mécanisme de l’immunité cérébrale dans la Neurovaccine. C. r. Soc. Biol. 86, 563 (1922).
Levaditi et Nicolau: (4) L’immunité tissulaire dans les ectodermoses neurotropes (neurovaccine). C. r. Acad. Sci. 176, 1768 (1923).
Levaditi et Nicolau: (5) Persistance du neurovaccin dans le testicule, l’ovaire et le poumon des animaux ayant acquis l’immunité antivaccinale. C. r. Acad. Sci. 177, 466 (1923).
Levaditi et Nicolau: (6) L’étiologie de l’encéphalite épidemique. C. r. Soc. Biol. 90, 1372 (1924).
196. Levaditi, Ravaut et Schoen: Propriétés virulicides du sérum des sujets atteints de lymphogranulomatose inguinale. Utilisation de la souris comme animal-test. C. r. Soc. Biol. 109, 1267 (1932).
197. Levaditi et Reinié: Irréversibilité de l’action virulicide exercée par le formol sur les éléments corpusculaires neurovaccinaux. C. r. Soc. Biol. 131, 1140 (1939).
198. Levaditi, Sanchis-Bayarri et Reinié: Le mécanisme des variations de la virulence des virus herpètiques et herpéto-encéphalitiques. Ann. Inst. Pasteur, Par. 41, 1292 (1927).
199. Levaditi, Sanchis-Bayarri et Schoen: Neuro-infections autostérilisables (Encéphalite, Herpès,. Rage). C. r. Soc. Biol. 98, 911 (1928).
200. Levinthal: Recent observations on psittacosis. Lancet 1935, 1207.
201. Little: Serum concentrate-living virus immunity against canine distemper. J. amer. vet. med. Assoc. 85 (38), 576 (1934).
202. Lloyd and Mahaffy: The use of guinea pigs in tests of immunity against yellow fever with small quantities of serum. Amer. J. trop. Med. 15, 51 (1935).
203. Lloyd, Theiler, and Ricci: Modification of the virulence of yellow fever virus by cultivation in tissues in vitro. Trans. roy. Soc. Med. a. Hyg. 29, 481 (1936).
204. Loeffler u. Schweinburg: (1) Rabizides Serum im Tierversuch. Wien. klin. Wschr. 1923, 813.
Loeffler u. Schweinburg: (2) Zur Theorie der Immunität bei Tollwut. Virchows Arch. 279, 181 (1930).
205. Löhe u. Schlossberger: Der heutige Stand unserer Kenntnisse vom Lymphogranuloma inguinale. Med. Klin. Nr. 43, 1427 (1937); Nr. 44, 1471 (1937).
206. Long and Olitzky: (1) Immunity in guinea pigs to the virus of vesicularstomatitis. Proc. Soc. exper. Biol. a. Med. (Am.) 25, 478 (1928).
Long and Olitzky: (2) Recovery of vaccine virus after neutralization with immune serum. J. exper. Med. (Am.) 51, 209 (1930).
207. Lyon and Wyckoff: Chick vaccine for equine encephalomyelitis. Vet. Med. 33, Nr. 9.
208. Mackenzie: Immunization of mice against Rift Valley fever. J. Path. a. Bacter. 40, 65 (1935).
209. Mackenzie and Findlay: (1) The production of a neurotropic strain of Rift Valley fever virus. Lancet 1936, 140.
Mackenzie and Findlay: (2) Variations in fowl pest virus. Brit. J. exper. Path. 18, 138 (1937).
210. McKendrick: Revue analytique des rapports des Instituts Pasteur sur les résultats de la vaccination antirabique. S. d. N. Org. d’Hygiène, Genève, 1930.
211. McKinley and Holden: Immunological studies in experimental encephalitis. Arch. Path. (Am.) 4, 155 (1927).
212. McKinnon: The union of vaccine virus and its specifie antiserum in vitro. J. prevent. Med. (Am.) 4, 411 (1930).
213. McMaster and Hudack: The formation of agglutinins within lymph nodes. J. exper. Med. (Am.) 61, 783 (1935).
214. McMaster and Kidd: Lymph nodes as a source of neutralizing principles for vaccinia. J. exper. Med. (Am.) 66, 73 (1937).
215. Madsen: Antitoxinbildcmg und Antitoxintherapie. Z. Hyg. 103, 447 (1924).
216. Madsen et Jensen: Rapport préliminaire sur l’emploi à titre d’étalon international d’un sérum de convalescent de poliomyélite. Bull. trimestr. Organisat. Hyg. Soc. Nat. (Schwz) 5, 770 (1936).
217. Magill and Francis: (1) Antigeriic differences in strains of human influenza virus. Proc. Soc. exper. Biol. a. Med. (Am.) 35, 463 (1936).
Magill and Francis: (2) Studies with human influenza virus cultivated in artificial medium. J. exper. Med. (Am.) 63, 803 (1936).
Magill and Francis: (3) The action of immune serum on human influenza virus in vitro. J. exper. Med. (Am.) 65, 861 (1937).
Magill and Francis: (4) Antigenic differences in strains of epidemic influenza virus. I. Cross neutralization tests in mice. Brit. J. exper. Path. 19, 273 (1938).
218. Magrassi: (1) Studii sull’infezione e sull’immunità da virus erpetico. Boll. Ist. sieroter. milan. 14, 773 (1935).
Magrassi: (2) Z. Hyg. 117, 501 (1935).
Magrassi: (3) Z. Hyg. 117, 573 (1935).
Magrassi: (4) L’infezione latente da virus vaccinico: Suo meccanismo e suoi rapporti coll’immunitè verso la superinfezione. Boll. Ist. sieroter. milan. 16, 345 (1937).
219. Magrassi e de Gregori: L’immunità verso la superinfezione nell’infezione vaccinica. Boll. Ist. sieroter. milan. 16, 505 (1937).
220. Magrassi e Hallauer: Sul meccanismo d’azione degli anticorpi protettivi nell’infezione vaccinica. Gi. Batter. 17, Nr. 6 (1936).
221. Magrassi e Muratori: Sul meccanismo dell’immunita nell’infezione vaccinica. Immunizzazione con virus non infettante. Boll. Ist. sieroter. milan. 16, 588 (1937).
222. Mahaffy, Lloyd, and Penna: Two years’ experience with the intraperitoneal protection test in mice in epidemiological studies of yellow fever. Amer. J. Hyg. 18, 618 (1933).
223. Maitland, Burbury, Hare, and Maitland: Investigations on footai]-and mouth disease by means of experiments with small animals during 1926/27. J. comp. Path. a. Ther. 41, 123 (1928).
224. Manninger: Über die Beziehungen der Newcastle-Krankheit zur Geflügelpest. Arch. wiss. u. prakt. Tierheilk. 65, 256 (1932).
225. Manteufel: Beiträge zur Kenntnis der Immunitätserscheinungen bei den sogenannten Geflügelpocken. Arb. ksl. Gesdh. amt, Berl. 33, 305 (1910).
226. Marie et Mutermilch: Nouveau essais de vaccination contre la rage. C. r. Soc. Biol. 98, 1314 (1928).
227. Merill: (1) Quantitative studies on the neutralization of equine encephalomyelitis virus by immune serum. I. Combination of virus and antibody in vitro. J. Immunol. (Am.) 30, 185 (1936).
Merill: (2) J. Immunol. (Am.) 30, 193 (1936).
228. Meyer and Eddie: (1) Latent psittacosis infections in Shell Parrakeets. Proc. Soc. exper. Biol. a. Med. (Am.) 30, 484 (1933).
Meyer and Eddie: (2) Latent psittacosis infections in mice. Proc. Soc. exper. Biol. a. Med. (Am.) 30, 483 (1933).
Meyer and Eddie: (3) Über Papageienpest. Klin. Wschr. Nr. 24, 865 (1934).
229. Michalka: Schweinepest (aktive Immunisierung). Wien. tierärztl. Wschr. 22, 33 (1935).
230. Minett: Immunity in Footai]-and Mouth disease. J. comp. Path. a. Ther. 40, 173 (1927).
231. Morgan and Fairbrother: The concentration of the protective substance in antipoliomyelitis serum. Brit. J. exper. Path. 11, 512 (1930).
232. Muckenfuss: Studies on the bacteriophage of d’Hérelle. J. exper. Med. (Am.) 48, 709 (1928).
233. Mueller: The effect of alexin in virus-antiserum mixtures. J. Immunol. (Am.) 20, 17 (1931).
234. Murillo: Experimentaluntersuchung über Antiwutserum. Zbl. Bakter. usw., Ref. 51, 409 (1912).
235. Nakagawa: Über die aktive Immunisierung des Hodens mittels parenchymatösen Einspritzungen des Variola-Vaccine-Koktoimmunogens. Z. Immunit. forsch. 42, 409 (1925).
236. Nattan-Larrier, Ramon et Grasset: Recherehes sur le passage des toxines et des antitoxines à travers le placenta. C. r. Soc. Biol. 96, 241 (1927).
237. Nelson: (1) The maternal transmission of vaccinial immunity in swine. J. exper. Med. (Am.) 56, 835 (1932).
Nelson: (2) J. exper. Med. (Am.) 60, 287 (1934).
238. Neufeld u. Meyer: Über die Bedeutung des Reticuloendothels für die Immunität. Z. Hyg. 103, 595 (1924).
239. Nicolau: Neuroinfections autostérilisées. C. r. Soc. Biol. 105, 177 (1930).
240. Nicolau, Cruveilhier et Kopciowska: Étude sur la pseudorage (Maladie d’Aujeszky) expérimentale. C. r. Soc. Biol. 126, 563 (1937).
241. Nicolau et Galloway: L’encéphalomyélite enzootique expérimentale (Maladie de Borna). Med. Res. Counc. Spec. Rep. No. 121 (1928); Ann. Inst. Pasteur, Par. 45, 457 (1930).
242. Nicolau et Kopciowska: (1) Herpès expérimental et immunité. C. r. Soc. Biol. 101, 334 (1929).
Nicolau et Kopciowska: (2) Identification d’un virus prétendu herpétique etc. Immunisation antirabique cutanée, à l’aide d’injections intradermiques répétées de virus formolé. C. r. Soc. Biol. 101, 655 (1929).
Nicolau et Kopciowska: (3) Réactivation a l’aide de la glycérine du virus herpétique dans le cerveau de certains lapins morts de “neuro-infection autostérilisée”. C. r. Soc. Biol. 104, 965 (1930).
Nicolau et Kopciowska: (4) Virus herpétique et cataphorèse. Impossibilité de mettre en évidence le virus herpétique dans le cerveau des animaux immunisés. C. r. Soc. Biol. 104, 1136 (1930).
Nicolau et Kopciowska: (5) Essais de réactivation, à l’aide de la glycérine ou de la cataphorèse, du virus rabique dans le cerveau de certains lapins morts de “neuro-infection autostérilisée”. C. r. Soc. Biol. 104, 1139 (1930).
Nicolau et Kopciowska: (6) Neuro-infections expérimentales, mortelles, partiellement autostérilisées, chez le lapin. C. r. Soc. Biol. 115, 1094 (1934).
Nicolau et Kopciowska: (7) Sur la transformation du virus rabique fixe en virus des rues. C. r. Acad. Sci. 198, 622 (1934).
243. Nicolau, Kopciowska et Constaninesco: Immunité et virus filtrables. Recherche par l’electrophorèse du virus herpétique dans le nevraxe des lapins immunisés. C. r. Soc. Biol. 106, llOO (1931).
244. Nicolau et Poincloux: (1) Herpès récidivant; caractères du virus herpétique. C. r. Soc. Biol. 87, 451 (1922).
Nicolau et Poincloux: (2) Étude clinique et expérimentale d’un cas d’Herpès récidivant du doigt. Aun. Inst. Pasteur, Par. 38, 977 (1924).
245. Nicolle et Conseil: Prévention de la Rougeoie au moyen de l’inoculation du sérum ou du sang complet des convalescents. Aun. Inst. Pasteur Afr. N. 1, 193 (1921).
246. Nocard et Roux: Expérience sur la vaccination des ruminants contre la rage par injection intraveineuse de virus rabique. Ann. Inst. Pasteur, Par. 2, 341 (1888).
247. Nye and Parker: Further observations on vaccine virus. Amer. J. Path. 5, 147 (1929).
248. Oerskov: Der bakterielle Infektionsmechanismus. Acta path. et microbiol. scand. (Dän.), Suppl. XI, 10 (1932).
249. Oerskov u. Andersen: (1) Untersuchungen am Kaninchen über lokale intrakutane Wachstums-und Immlmitätsvorgänge bei Vaccineinfektion. Z. Immunit. forsch. 92, 487 (1938).
Oerskov u. Andersen: (2) Weitere Untersuchungen über die Bildungsstätten der virusneutralisierenden Stoffe bei Vaccineinfektion von Kaninchen. Intratesticuläre Infektionen. Acta path. et microbiol. scand. (Dän.), Suppl. 37 (1938).
250. Oerskov, Hansen et Schmidt: Recherches sur le mécanisme de l’infection aphteuse chez le cobaye. Rev. Immunol. (Fr.) No. 6, 583 (1936).
251. Oerskov u. Schmidt: Infektionsmechanische Untersuchungen über die Geflügelpestinfektion der Maus. etc. Zbl. Bakter. usw., I Orig. 137, 1 (1936).
252. Okawachi: Experimentelle Untersuchungen über die Schutzkraft des Variola-Vaccineserums. Z. Immunit. forsch. 41, 62 (1924).
253. Olitzky: Physical, chemical and biological studies on the virus of vesicularstomatitis of horses. J. exper. Med. (Am.) 45, 969 (1927).
254. Olitzky and Cox: (1) Experiments on active immunization against experimental poliomyelitis. J. exper. Med. (Am.) 63, 109 (1936).
Olitzky and Cox: (2) Active immunization of guinea pigs with the virus of equine encephalomyelitis. I. Quantitative experiments with various preparations of active virus. J. exper. Med. (Am.) 63, 311 (1936).
255. Olitzky and Harford: (1) Intraperitoneal and intracerebral routes in serum protection tests with the virus of equine encephalomyelitis. I. A comparison of the two routes in protection tests. J. exper. Med. (Am.) 68, 173 (1938).
Olitzky and Harford: (2) II. Mechanism underlying the difference in protective power by the two routes. J. exper. Med. (Am.) 68, 761 (1938).
Olitzky and Harford: (3) III. Comparison of antiviral serum constituents from guinea pigs immunized with active or formolized inactive virus. J. exper. Med. (Am.) 68, 779 (1938).
256. Olitzky and Long: (1) The action of the Levaditi strain of herpes virus, and of vaccine virus in the guinea pigs. J. exper. Med. (Am.) 48, 379 (1928).
Olitzky and Long: (2) Relation of vaccinal immunity to the persistence of the virus in rabbits. J. exper. Med. (Am.) 50, 263 (1929).
257. Olitzky, Rhoads, and Long: Effect of cataphoresis on poliomyelitis virus. J. exper. Med. (Am.) 50, 273 (1929).
258. Olitzky, Sabin, and Cox: (1) Variations in neuroinvasivness of certain viruses in relation to the age of susceptible hosts. Amer. J. Path. 11, 839 (1935).
Olitzky, Sabin, and Cox: (2) An acquired resistance of growing animals to certain neurotropic viruses in the absence of humoral antibodies or previous exposure to infection. J. exper. Med. (Am.) 64, 723 (1936).
259. Olitzky, Traum, and Schoening: Comparative studies on vesicularstomatitis and foot-and mouth disease. J. amer. vet. med. Assoc. 70 (23), 147 (1926).
260. Otto u. Munter: Das bacteriophage Lysin, seine Beziehungen zum Bakterium und zu dem Antilysin. Z. Hyg. 98, 302 (1922).
261. Parker and Rivers: Immunological and chemical investigations of vaccine virus. III. Response of rabbits to inactive elementary bodies of vaccinia and to virus-free extracts of vaccine virus. J. exper. Med. (Am.) 63, 69 (1936).
262. Paschen: Über zweitägige Vakzine. Dtsch. med. Wschr. 1926, 1301, 2125.
263. Paul and Trask: (1) A comparative study of recently isolated human strains and a passage strain of poliomyelitis virus. J. exper. Med. (Am.) 58, 513 (1933).
Paul and Trask: (2) The neutralization test in poliomyelitis. Comparative results with four strains of the virus. J. exper. Med. (Am.) 61, 447 (1935).
264. Pauli: Sulla sieroterapia della poliomielite anteriore acuta infettiva. Boll. Ist. sieroter. milan (1934).
265. Perdrau: (1) Inactivation and reactivation of the virus of herpes. Proc. roy. Soc., Lond., Ser. B: Biol. Sci. 109, 304 (1931).
Perdrau: (2) Persistence of the virus of herpes in rabbits immunised with living virus. J. Path. a. Bacter. 47, 447 (1938).
266. Perdrau and Todd: (1) The photodynamic action of methylen blue on bacteriophage. Proc. roy. Soc., Lond., Ser. B: Biol. Sci. 112, 277 (1933).
Perdrau and Todd: (2) The photodynamic action of methylen blue on certain viruses. Proc. roy. Soc., Lond., Ser. B: Biol. Sci. 112, 288 (1933).
Perdrau and Todd: (3) Canine distemper. The high antigenie value of the virus after photodynamic inactivation bymethylen blue. J. comp. Path. a. Ther. 46, 78 (1933).
Perdrau and Todd: (4) The relation of pathogenie viruses to the cells of their hosts. Proc. roy. Soc., Lond., Ser. B: Biol. Sci. 121, 253 (1936).
267. Pettit, Stefanopoulo et Frasey: Pouvoir préventif et curatif du sérum antiamaryllique. C. r. Soc. Biol. 99, 1114 (1928).
268. Pfeiffer u. Marx: Die Bildungsstätte der Choleraantikörper. Z. Hyg. 27, 272 (1898).
269. Pfeiler: Über Immunisierungsversuche bei Tollwut. Berl. tierärztl. Wschr. Nr. 14, 249, 269 (1913).
270. Ponomareff et Solovieff: Nouveau procédé de la préparation du vaccin antirabique et essai d’application de ce vaccin pour l’obtention d’un sérum antirabique de haute activité. Ann. Inst. Pasteur, Par. 42, 1661 (1928).
271. Ponomareff et Tschechkoff: Les conditions de l’action du sérum antirabique. C. r. Soc. Biol. 97, 376 (1927).
272. Prausnitz: Untersuchungen über den d’Herelleschen Bakteriophagen. Zbl. Bakter. usw., I Orig. 89, 187 (1922).
273. Proca, Bobes et Jonnesco: (1) Sur la sérothérapie préventive de la rage. C. r. Soc. Biol. 115, 1001 (1934).
Proca, Bobes et Jonnesco: (2) Inoculation intracaudale du virus rabique et sérothérapie de la rage. C. r. Soc. Biol. 115, 1313 (1934).
274. Purdy: Immunologic reactions with tobacco mosaicvirus. Proc. Soc. exper. Biol. a. Med. (Am.) 25, 702 (1928); J. exper. Med. (Am.) 49, 919 (1929).
275. Remlinger: Contribution à l’étude de la transmission héréditaire de l’immunité antirabique. Ann. Inst. Pasteur, Par. 23, 430 (1909).
276. Remlinger et Bailly: Contribution à l’étude du virus de la maladie d’Aujeszky. Ann. Inst. Pasteur, Par. 59, 1 (1937).
277. Repetto: cit. nach Schweinburg (310).
278. Rhoads: (1) Immunity following the injection of monkeys with mixtures of poliomyelitis virus and convalescent human serum. J. exper. Med. (Am.) 53, 115 (1931).
Rhoads: (2) Immunization against vaccinia by non-infective mixtures of virus and immune serum. J. exper. Med. (Am.) 53, 185 (1931).
Rhoads: (3) Immunization with mixtures of poliomyelitis virus and aluminum hydroxide. J. exper. Med. (Am.) 53, 399 (1931).
279. Rickard and Francis: The demonstration of lesions and virus in the lung of mice receiving large intraperitoneal inoculations of epidemic influenza virus. J. exper. Med. (Am.) 67, 953 (1938).
280. Rivers, Haagen, and Muckenfuss: A study of vaccinial immunity in tissue cultures. J. exper. Med. (Am.) 50, 673 (1929).
281. Rivers and Schwentker: Vaccination of monkeys and laboratory workers against psittacosis. J. exper. Med. (Am.) 60, 211 (1934).
282. Rivers, Schwentker, and Finkelstein: Observations on the immunological relation of poliomyelitis to louping ill. J. exper. Med. (Am.) 57, 955 (1933).
283. Rivers and Tillet: Local passive immunity in the skin of rabbits to infection with (1) a filterable virus and (2) hemolytic streptococci. J. exper. Med. (Am.) 41, 185 (1925).
284. Robles: Rinderpest studies. Philippine J. Sci. 60, 361 (1936).
285. Ross and Stanley: Partial reactivation of formolized tobacco mosaicvirus protein. Proc. Soc. exper. Biol. a. Med. (Am.) 38, 260 (1938); J. gen. Physiol. (Am.). 22, 165 (1938).
286. Rous, Kidd, and Beard: Observations on the relation of the virus causing rabbit papillomas to the cancer deriving therefrom. I. The influence of the host species and of the pathogenic activity and concentration of the virus. J. exper. Med. (Am.) 64, 385 (1936).
287. Rous, McMaster, and Hudack: (1) The fixation of certain viruses on the cells of susceptible animals and protection affordet by such cells. Proc. Soc. exper. Biol. a. Med. (Am.) 31, 90 (1933/34).
Rous, McMaster, and Hudack: (2) The fixation and protection of viruses by the cells of susceptible animals. J. exper. Med. (Am.) 61, 657 (1935).
288. Sabin: (1) Studies on the B-Virus. I. The immunological identity of a virus isolated from a human case of ascending myelitis associated with visceral necrosis. Brit. J. exper. Path. 15, 248 (1934).
Sabin: (2) The mechanism of immunity to filterable viruses. I. Does the virus combine with the protective substance in immune serum in the absence of tissue? Brit. J. exper. Path. 16, 70 (1935).
Sabin: (3) II. Fate of the virus in a system consisting of susceptible tissue, immune serum and virus, and the röle of the tissue in the mechanism of immunity. Brit. J. exper. Path. 16, 84 (1935).
Sabin: (4) III. Rôle of leucocytes in immunity to vaccinia. Brit. J. exper. Path. 16, 158 (1935).
Sabin: (5) IV. The nature of the varying protective capacity of antiviral serum in different tissues of the same species and in the same tissues of different species. Brit. J. exper. Path. 16, 169 (1935).
Sabin: (6) Studies on the mechanism of immunity in certain virus diseases. J. Immunol. (Am.) 29, 73 (1935).
Sabin: (7) Studies on the mechanism of immunity in certain virus diseases. Amer. J. Path. 11, 832 (1935)
Sabin: (8) The protective action of nasally instilled immune serum against infection with certain neurotropic viruses by way of the nose. J. exper. Med. (Am.) 63, 863 (1936).
Sabin: (9) Progression of different nasally instilled viruses along different nervous pathwaysin thesame host. Proc. Soc. exper. Biol. a. Med. (Am.) 38, 270 (1938).
289. Sabin and Olitzky: (1) Humoral antibodies and resistance of vaccinated and convalescent monkeys to poliomyelitis virus. J. exper. Med. (Am.) 64, 739 (1936).
Sabin and Olitzky: (2) Toxoplasma and obligate intracellular parasitism. Science 85, 336 (1937).
Sabin and Olitzky: (3) Influence of host factors on neuromvasivness of vesicularstomatitis virus. I. Effect of age on the invasion of the brain by virus instilled in the nose. J. exper. Med. (Am.) 66, 15 (1937).
Sabin and Olitzky: (4) II. Effect of age on the invasion of the peripherial and central nervous systems by virus injected into the leg muscle or the eye. J. exper. Med. (Am.) 66, 35 (1937).
Sabin and Olitzky: (5) III. Effect of age and pathway of infection on the character and Iocalization of lesions in the central nervous system. J. exper. Med. (Am.) 67, 201 (1938).
Sabin and Olitzky: (6) IV. Variations in neuroinvasiveness in different species. J. exper. Med. (Am.) 67, 229 (1938).
Sabin and Olitzky: (7) Fate of nasally instilled poliomyelitis virus in normal and convalescent monkeys with special reference to the problems of host to host transmission. J. exper. Med. (Am.) 68, 39 (1938).
290. Salaman: The combining properties of vaccinia virus with the antibodies demonstrable in antivaccinial serum. Brit. J. exper. Path. 18, 245 (1937).
291. Sato: (1) Experimentelle Beiträge zur Vaccineimmunität. Z. Immunit. forsch. 32, 481 (1921).
Sato: (2) Untersuchungen über immunitätsreaktionen bei Geflügelpocken. Z. Immunit. forsch. 46, 23 (1926).
292. Sawyer: The duration of yellow fever immunity after vaccination and after the disease. Trans. Assoc. amer. Physicians 1, 64 (1935).
293. Sawyer, Kitchen, and Lloyd: Vaccination against yellow fever with immune serum and virus fixe for mice. J. exper. Med. (Am.) 55, 945 (1932).
294. Sawyer and Lloyd: The use of mice in tests of immunity against yellow fever. J. exper. Med. (Am.) 54, 533 (1931).
295. Scalfi: (1) Sull’azione immunizzante di tessuti di conigli portatori d’infezione vaccinica. Ann. Ig. 48, 137 (1938).
Scalfi: (2) Il problema dei rapporti tra infezione latente e immunita, studiato a mezzo di minime dosi di virus vaccinico (dosi subpathogene). Ann. Ig. 49, 429 (1939).
296. Scott and Rivers: Meningitis in man caused by a filterable virus. J. exper. Med. (Am.) 63, 397 (1936).
297. Schlossmann u. Herzberg-Kremmer: Über Vaccineimmunität bei Müttern und ihren Neugeborenen. Z. Kinderhk. 53, 686 (1932).
298. Schmidt: (1) Sur l’effet immunisant d’un adsorbat virus aphteux-hydroxyde d’aluminium inactivé par la chaleur comparé à celui d’un adsorbat renfermant du virus non attenué. Rev. Immunol. (Fr.) 2, 580 (1936).
Schmidt: (2) Adsorption von Maul-und Klauenseuchevirus an Aluminiumhydroxyd unter besonderer Berücksichtigung der immunisierenden Eigenschaften des Virusadsorbates. Z. Immunit. forsch. 92, 392 (1938).
299. Schmidt et Oerskov: Adsorption du virus de la peste aviaire par l’hydroxyde d’aluminium. Acta path. et microbiol. scand. (Dän.) 12, 262 (1935).
300. Schmidt, Oerskov et Hansen: Comparaison du pouvoir immunisant du complexe virus aphteux-hydroxyde d’Aluminium inactivé d’une part, in vivo, et d’autre part, in vitro. C. r. Soc. Biol. 123, 721 (1936).
301. Schmidt, Oerskov et Steenberg: (1) Immunisation active contre la peste aviaire. Kong. dansk. Vidensk. Selsk., biol. Medd. 12, 6 (1936).
Schmidt, Oerskov et Steenberg: (2) Studien über die experimentelle Geflügelpest. VI. Mitteilung. Z. Hyg. 118, 455 (1936).
302. Schmit-Jensen, Schmidt et Hansen: Immunisation active du cobaye contre la fiévre aphteuse au moyen du virus non attenué, combiné avec l’hydroxyde d’aluminium. Rev. Immunol. (Fr.) 2, 359 (1936).
303. Schnürer u. David: Die Schutzimpfung der Hunde gegen Wut. Weichhardtsche Erg. Hyg. 11, 556 (1930).
304. Schoen: La réinfection névraxique des souris blanches avec le virus de la maladie de Nicolas et Favre. C. r. Soc. Biol. 131, 475 (1939).
305. Schultz: Die antigenen Eigenschaften der ultravisiblen Virusarten. Erg. Hyg. usw. 9, 184 (1928).
306. Schultz and Gebhardt: (1) Immune serum production in poliomyelitis refractory animals. J. Immunol. (Am.) 26, 93 (1934).
Schultz and Gebhardt: (2) Observations on the prophylactic value of specific immune serum in experimental poliomyelitis. J. Pediatr. (Am.) 7, 332 (1935).
Schultz and Gebhardt: (3) On the problem on immunization against poliomyelitis. California a. west. Med. 43, 111 (1935).
Schultz and Gebhardt: (4) Nature of formalin inactivation of bacteriophage. Proc. Soc. exper. Biol. a. Med. (Am.) 32, 1111 (1935).
307. Schultz, Gebhardt, and Bullock: Studies on the antigenic properties of the viricidal antibody in antipoliomyelitic serum. J. Immunol. (Am.) 21, 171 (1931).
308. Schultz and Hartley: Protective action of specific serum against experimental vaccinia in rabbits. Proc. Soc. exper. Biol. a. Med. (Am.) 34, 294 (1936).
309. Schultz, Quigley, and Bullock: The Antigenic properties of the Bacteriophage. V. J. Immunol. (Am.) 17, 245 (1929).
310. Schweinburg: Neuere Ergebnisse der Tollwutforschung. Weichhardtsche Erg. 20, 1 (1937).
311. Seidenberg u. Whitman: Zur Frage der anaphylaktogenen Eigenschaften des Diphtherietoxins. Z. Hyg. 113, 125 (1932).
312. Seiffert: Neue Tierversuche mit Vaccinevirus. Zbl. Bakter. usw., I Orig. 122, 222 (1931).
313. Seiser: Untersuchungen über das Phänomen von d’Hérelle. Arch. Hyg. (D.) 92, 189 (1923).
314. Sellards and Bennett: Vaccination in yellow fever with non-infective virus. Ann. trop. Med. 31, 373 (1937).
315. Shahan and Giltner: Some aspects of infection and immunity in equine encephalomyelitis. J. amer. vet. med. Assoc. 84 (37), 928 (1934).
316. Shope: (1) An experimental study of “mad itch” with especial reference to its relationship to pseudorabies. J. exper. Med. (Am.) 54, 233 (1931).
Shope: (2) Studies on immunity to swine influenza. J. exper. Med. (Am.) 56, 575 (1932).
Shope: (3) Serial transmission of virus of infectious papillomatosis in domestic rabbits. Proc. Soc. exper. Biol. a. Med. (Am.) 32, 830 (1933).
Shope: (4) Infectious papillomatosis of rabbits. J. exper. Med. (Am.) 58, 607 (1933).
Shope: (5) The infection of mice with swine influenza virus. J. exper. Med. (Am.) 62, 561 (1935).
Shope: (6) Infectious fibroma of rabbits. IV. The infection with virus myxomatosum recovered from fibroma. J. exper. Med. (Am.) 63, 43 (1936).
Shope: (7) Immunization experiments with swine influenza virus. J. exper. Med. (Am.) 64, 47 (1936).
Shope: (8) Immunization of rabbits to infectious papillomatosis. J. exper. Med. (Am.) 65, 219 (1937).
Shope: (9) Immunological relationships between the swine and human influenza viruses in swine. J. exper. Med. (Am.) 66, 151 (1937).
Shope: (10) Serological studies of swine influenza viruses. J. exper. Med. (Am.) 69, 847 (1939).
317. Shope and Francis: The susceptibility of swine to the virus of human influenza. J. exper. Med. (Am.) 64, 791 (1936).
318. Smith: (1) The distribution of virus and neutralizing antibodies in the blood and pathological exsudates of rabbits infected with vaccinia. Brit. J. exper. Path. 10, 93 (1929).
Smith: (2) Specific antibody absorption by the viruses of vaccinia and herpes. J. Path. a. Bacter. 33, 273 (1930).
319. Smith and Andrewes: Serological races of influenza virus. Brit. J. exper. Path. 19, 293 (1938).
320. Smith, Andrewes, and Laidlaw: Influenza: Experiments on the immunization of ferrets and mice. Brit. J. exper. Path. 16, 291 (1935).
321. Smith and Theiler: The adaption of unmodified strains of yellow fever virus to cultivation in vitro. J. exper. Med. (Am.) 65, 801 (1937).
322. Sobernheim: (1) Die neueren Anschauungen über das Wesen der Variola-und Vaccine-Immunität. Weiehhardtsche Erg. 7, 133 (1925).
Sobernheim: (2) Milzbrand in Kolle, Kraus, Uhlenhuth: Handbuch der pathogenen Mikroorganismen, Bd. III, S. 1135. 1931.
323. Soper, Beeuwkes, Davis, and Kerr: Transitory immunity to yellow fever in the offspring of immune human and monkey mothers. Amer. J. Hyg. 27, 351 (1938).
324. Soper and Smith: Yellow fever vaccination with cultivated virus and immune and hyperimmune serum. Amer. J. trop. Med. 18, 111 (1938).
325. Stefanopoulo et Nagano: Sur la transmission de l’immunité antiamarile de la mère au nouveau-né. C. r. Soc. Biol. 128, 334 (1938).
326. Steinhardt and Lambert: Studies on the cultivation of the virus of vaccinia. J. infect. Dis. (Am.) 14, 87 (1914).
327. Sternberg: Practical results of bacteriology. Trans. Assoc. amer. Physicians 1892, 98.
328. Stewart and Rhoads: Intradermal versus subeutaneous immunization of monkeys against poliomyelitis. J. exper. Med. (Am.) 49, 959 (1929).
329. Stoel: Culture in vitro du virus vaccinal et immunité antivaccinale. Arch. exper. Zellforsch. 10, 452 (1931).
330. Stokes, Bauer, and Hudson: Experimental transmission of yellow fever to laboratory animals. Amer. J. trop. Med. 8, 103 (1928).
331. Stuart-Harris, Andrewes, and Smith: A Study of epidemic influenza. Med. Res. Counc. Spec. Rep. No. 228 (1938).
332. Stuart-Harris and Francis: Studies on the nasal histology of epidemic influenza virus infection in the ferret. II. The resistance of regenerating respiratory epithelium to reinfection and to physico chemical injury. J. exper. Med. (Am.) 68, 803 (1938).
333. Stuart and Krikorian: (1) Studies in antirabies immunization. J. Hyg. (Brit.) 29, 1 (1929).
Stuart and Krikorian: (2) Further studies in antirabies immunization. J. Hyg. (Brit.) 31, 523 (1931).
334. Taliaferro: Infection and resistance in the blood inhabiting protozoa. Science 75, 619 (1932).
335. Theiler: (1) Studies on the action of yellow fever virus in mice. Ann. trop. Med. 24, 249 (1930).
Theiler: (2) Neutralization tests with immune yellow fever sera and an strain of yellow fever virus adapted to mice. Ann. trop. Med. 25, 69 (1931).
Theiler: (3) A yellow fever protection test in mice by intracerebral injection. Ann. trop. Med. 27, 57 (1933).
Theiler: (4) Spontanous encephalomyelitis of mice. A new virus disease. J. exper. Med. (Am.) 65, 705 (1937).
336. Theiler and Hughes: Studies of circulating virus and protective antibodies in susceptible and relatively insusceptible monkeys after inoculation with yellow fever virus. Trans. Soc. trop. Med. 28, 481 (1935).
337. Theiler and Sellards: The immunological relationship of yellow fever as it occurs in West Africa and in South America. Ann. trop. Med. 22, 449 (1928).
338. Theiler and Smith: (1) The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. J. exper. Med. (Am.) 65, 767 (1937).
Theiler and Smith: (2) The use of yellow fever virus modified by in vitro cultivation for human immunization. J. exper. Med. (Am.) 65, 787 (1937).
339. Theiler and Whitman: Quantitative studies of the virus and immune serum used in vaccination against yellow fever. Amer. J. trop. Med. 15, 347 (1935).
340. Teissier, Gastinel et Reilly: Apropos de l’immunité herpètique et du pouvoir neutralisant des tissus in vitro. C. r. Soc. Biol. 98, 1399 (1928).
341. ten Broeck, Hurst, and Traub: Epidemiology of equine encephalomyelitis in the Eastern United states. J. exper. Med. (Am.) 62, 677 (1935).
342. ten Broeck and Merill: A serological difference between Eastern and Western equine Encephalomyelitisvirus. Proc. Soc. exper. Biol. a. Med. (Am.) 31, 217 (1933).
343. Thompson: Allergic reactions in vaccinia immune rabbits. J. Immunol. (Am.) 19, 63 (1930).
344. Todd: On a dilution phenomen observed in the titration of the serum of fowls immunized against the virus of fowl plague. Brit. J. exper. Path. 9, 244 (1928).
345. Toomey: Poliomyelitis antiserum obtained from horses. Amer. J. Dis. Childr. 53, 1492 (1937).
346. Topacio and Robles: Immunity in Rinderpest vaccinated animals. Philipp. J. Sci. 60, 387 (1936).
347. Topacio and Hyde: The behaviour of rabbit virus III in tissue culture. Amer. J. Hyg. 15, 99 (1932).
348. Toshio Abe: Über das Virus der Maul-und Klauenseuche. Z. Infekt. krkh. Haustiere 28, 111 (1925).
349. Trask, Paul, Beebe, and German: Viruses of poliomyelitis. An immunological comparison of six strains. J. exper. Med. (Am.) 65, 687 (1937).
350. Traub: (1) Multiplication in vitro of pseudorabies virus in the testicle tissue of immunized guinea pigs. J. exper. Med. (Am.) 61, 833 (1935).
Traub: (2) An epidemic in a mouse colony due to the virus of acute lymphocytic choriomeningitis. J. exper. Med. (Am.) 63, 533 (1936).
Traub: (3) Persistence of lymphocytic choriomeningitis virus in immune animals and its relation to immunity. J. exper. Med. (Am.) 63, 847 (1936).
Traub: (4) Immunization of guinea pigs with a modified strain of lymphocytic choriomeningitis virus. J. exper. Med. (Am.) 66, 317 (1937).
Traub: (5) Immunization of guinea pigs against lymphocytic choriomeningitis with formolized tissue vaccines. J. exper. Med. (Am.) 68, 95 (1938).
Traub: (6) Factors influencing the persistence of choriomeningitis virus in the blood of mice after clinical recovery. J. exper. Med. (Am.) 68, 229 (1938).
Traub: (7) Über Immunität und aktive Immunisierung gegen Viruskrankheiten. Z. Infekt. krkh. Haustiere 54, 169 (1939).
351. Traub u. Schaefer: Serologische Untersuchungen über die Immunität der Mäuse gegen die lymphozitische Choriomeningitis. Zbl. Bakter. usw., I Orig. 144, 331 (1939).
352. Traub and ten Broeck: Protective vaccination of horses with modified equine encephalomyelitis virus. Science 81, 572 (1935).
353. Trautwein: Maul-und Klauenseuche. Weichhardts Erg. Hyg. 10, 636 (1929).
354. Tulloch: The serological diagnosis of small pox and the laboratory investigations of vaccinia. J. State Med. 42, 683 (1934).
355. Turró et Domingo: Les anticorps locaux dans les immunités locales. C. r. Soc. Biol. 88, 410 (1923).
356. Vallée, Carré, and Rinjard: (1) Vaccination against foot-and mouth disease by means of formalinised virus. J. comp. Path. a. Ther. 39, 326 (1926).
Vallée, Carré, and Rinjard: (2) Sur la vaccination antiaphteuse. Rev. gén. méd. vét. 37, 257 (1928).
357. Vieuchange: (1) Action des extraits testiculaires sur le mélange virus vaccinal-immunsérum inoculé par voie intradermique. C. r. Soc. Biol. 128, 901 (1938).
Vieuchange: (2) Influence des voies d’inoculation (voie cerebrale en particulier) sur les mélanges de virus vaccinal et d’immunsérum. C. r. Soc. Biol. 128, 953 (1938).
358. Vieuchange et Galli: (1) Étude du mécanisme de la réactivation du neurovaccin formolé par la dialyse. C. r. Soc. Biol. 131, 627 (1939).
Vieuchange et Galli: (2) Présence d’un facteur neutralisant dans la lésion cutanée provoquée par l’inoculation intradermique de virus vaccinal. C. r. Acad. Sci. 208, 2031 (1939).
359. Vieuchange et Mesrobeanu: Influence de la membrane chorio-allantoidienne de l’embryon de poulet sur les mélanges de virus vaccinal et d’antisérum. C. r. Soc. Biol. 128, 951 (1938).
360. Wagemans: Sur la constitution des Bactériophages et leur neutralisation. Arch. internat. Pharmacodynam. 28, 181 (1923).
361. Wagener: (1) Infektion und Immunität bei der experimentellen Aphthenseuche der Meerschweinchen. Arch. wiss. u. prakt. Tierheilk. 56, 494 (1927).
Wagener: (2) Infection and immunity of vesicularstomatitis in guinea pigs. Vet. Med. 26, 388 (1931).
Wagener: (3) Foot-and mouth disease and vesicularstomatitis. J. amer. vet. med. Assoc. 80 (33), 39 (1932).
Wagener: (4) Investigations on the passive immunization of small animals in vesicularstomatitis. J. amer. vet. med. Assoc. 80 (33), 579 (1932).
Wagener: (5) Investigations on the virulence of vesicularstomatitis virus and the properties of immune sera. J. amer. vet. med. Assoc. 81 (34), 160 (1932).
Wagener: (6) Stomatitis vesicularis und Maul-und Klauenseuche. II. Wechselbeziehungen zwischen Virus und Tierkörper. Arch. wiss. u. prakt. Tierheilk. 66, 301 (1933).
362. Wahl et Lewi: Étude comparée du pouvoir antigénique du bactériophage libre et fixé sur l’alumine, en injection unique. C. r. Soc. Biol. 131, 749 (1939).
363. Waldmann, Köbe u. Pyl: Die aktive Immunisierung des Rindes gegen Maul-und Klauenseuche mittels Formolimpfstoff. Zbl. Bakter. usw., I Orig. 138, 401 (1938).
364. Waldmann u. Pape: Experimentelle Untersuchungen über Maul-und Klauenseuche. Die Wertbemessung der Maul-und Klauenseuche. Berl. tierärztl. Wschr. 37, 445 (1921).
365. Waldmann u. Reppin: Experimentelle Untersuchungen zur aktiven Immunisierung gegen Maul-und Klauenseuche. Z. Infekt. krkh. Haustiere 47, 283 (1935).
366. Waldmann u. Trautwein: (1) Die Maul-und Klauenseucheimmunität nach künstlicher und spontaner Infektion sowie nach simultaner Impfung. Zbl. Bakter. usw., I Orig. 90, 448 (1923).
Waldmann u. Trautwein: (2) Über die Prüfung und Wertigkeit bei Maul-und Klauenseucheserum. Berl. tierärztl. Wschr. 44, 205 (1928).
367. Waldmann, Trautwein u. Pyl: Die Persistenz des Maul-und Klauenseuchevirus im Körper durchgeseuchter Tiere und seine Ausscheidung. Zbl. Bakter. usw., Ref. 121, 19 (1931).
368. Walsh and Cannon: Immunization of the respiratory tract. J. Immunol. (Am.) 35, 31 (1938).
369. Wassén: Transmission de la lymphogranulomatose inguinale au cobaye. C. r. Soc. Biol. 116, 121 (1934).
370. Webster: (1) Diagnostic and immunological tests of rabies in mice. Amer. J. publ. Health 26, 1207 (1936).
Webster: (2) Epidemiologic and immunologic experiments on rabies. New Engld J. Med. 217, 687 (1937).
Webster: (3) Japanese B Encephalitis virus: its differentiation from St. Louis encephalitis virus and relationship to louping ill virus. J. exper. Med. (Am.) 67, 609 (1938).
Webster: (4) Immunity of mice following subcutaneous vaccination with St. Louis encephalitis virus. J. exper. Med. (Am.) 68, 111 (1938).
Webster: (5) Experiments on antirabic vaccination with tissue culture virus. Amer. J. publ. Health 28, 44 (1938).
Webster: (6) A mouse test for measuring the immunizing potency of antirabies vaccines. J. exper. Med. (Am.) 70, 87 (1939).
371. Webster and Clow: (1) Propagation of rabies virus in tissue culture and the successfull use of culture virus as an antirabic vaccine. Science 84, 487 (1936).
Webster and Clow: (2) The limited neurotropic character of the encephalitis virus (St. Louis type) in susceptible mice. J. exper. Med. (Am.) 63, 433 (1936).
Webster and Clow: (3) Experimental Encephalitis (St. Louis type) in mice with high inborn resistance. J. exper. Med. (Am.) 63, 827 (1936).
372. Webster and Dawson: Early diagnosis of rabies by mouse inoculation. Measurement of humoral immunity to rabies by mouse protection test. Proc. Soc. exper. Biol. a. Med. (Am.) 32, 570 (1935).
373. Webster and Fite: Experimental studies on encephalitis. Science 78, 463 (1933).
374. Weyer: (1) Immunological differences between astrain of monkey virus and human poliomyelitis virus. Proc. Soc. exper. Biol. a. Med. (Am.) 29, 289 (1931).
Weyer: (2) Herpes antiviral substances. Distribution in various age groups and apparent absence in individual susceptible to poliomyelitis. Proc. Soc. exper. Biol. a. Med. (Am.) 30, 309 (1932/33).
375. Weyer, Park, and Banzhaf: (1) Refined Anti-Poliomyelitis. Amer. J. Path. 5, 517 (1929).
Weyer, Park, and Banzhaf: (2) A potent antipoliomyelitic horse serum and its experimental use in infected monkeys. J. exper. Med. (Am.) 53, 553 (1930).
376. Wooley, Armstrong, and Onstott: The occurence in the sera of man and monkeys of protective antibodies against the virus of lymphocytic choriomeningitis as determined by the serum-virus. Publ. Health Pap. a. Rep. (Am.) 52, 1105 (1937).
377. Zinsser and Tang: Further experiments on the agent of herpes. J. Immunol. (Am.) 17, 343 (1929).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Additional information
Besonderer Hinweis
Dieses Kapitel ist Teil des Digitalisierungsprojekts Springer Book Archives mit Publikationen, die seit den Anfängen des Verlags von 1842 erschienen sind. Der Verlag stellt mit diesem Archiv Quellen für die historische wie auch die disziplingeschichtliche Forschung zur Verfügung, die jeweils im historischen Kontext betrachtet werden müssen. Dieses Kapitel ist aus einem Buch, das in der Zeit vor 1945 erschienen ist und wird daher in seiner zeittypischen politisch-ideologischen Ausrichtung vom Verlag nicht beworben.
Rights and permissions
Copyright information
© 1938 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hallauer, C. (1938). Die erworbene Immunität gegen Virusinfektionen. In: Doerr, R., Hallauer, C., Craigie, J., Findlay, G.M., Smith, K.M., Thomsen, O. (eds) Handbuch der Virusforschung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-42438-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-42438-4_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-42169-7
Online ISBN: 978-3-662-42438-4
eBook Packages: Springer Book Archive